Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Pediatric proton therapy

08/09/2019
/ Publications
/
Dosimetry
Secondary cancer

A review article that emphasizes proton beam therapy is an important therapeutic component in multidisciplinary management in pediatric oncology because of...

IMPT - The future of IMRT for head and neck cancer.

01/01/2019
/ Publications
/
IMRT
Dosimetry
Imaging System
Reirradiation

A review article looked at the development of RT advances. There is a growing awareness of the potential clinical benefits of proton therapy over IMRT in the...

Proton beam therapy for cancer in the era of precision medicine.

11/12/2018
/ Publications
/
Dosimetry
Reirradiation

A general review on PBT inlcuding dosimetric advantage, clinical data on PBT for ocular tumor, skull base, paraspinal tumors (chondrosarcoma and chordoma), and...

Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors?

04/04/2018
/ Publications
/
Dosimetry

A review by the MD Anderson group examined the available data with regard to proton therapy for thoracic malignancies, and presented the unique challenges in...

Proton therapy significantly reduced toxicity compared with IMRT

08/02/2016
/ Publications
/
Toxicity
Dosimetry
IMRT

A retrospective study reported that proton therapy significantly reduced toxicity compared with IMRT for head and neck tumors. The toxicity outcome confirm the...

CT-on-Rails Versus In-Room CBCT for Online Daily Adaptive Proton Therapy of Head-and-Neck Cancers

11/11/2021
/ Publications
/
Dosimetry

This study compared the efficacy of CT-on-rails versus in-room CBCT for daily adaptive proton therapy. CT-on-rails provides high precision accuracies, but the...

Proton Beam Therapy versus Photon Radiotherapy for Stage I Non-Small Cell Lung Cancer.

13/09/2022
/ Publications
/
Dosimetry

Published by the NCC group, Korea, this study reported clinical outcomes and dosimetry comparison of 289 patients with stage I NSCLC treated with protons (n=112...

Treating head and neck cancer with proton therapy

30/12/2020
/ White Paper
/
Toxicity
IMRT
Dosimetry

Proton particles do not deposit exit dose, which allows proton therapy to spare normal tissues distal to the tumor target. This is particularly useful for...

Long-term outcomes of high-dose (74 GyE) proton beam therapy with concurrent chemotherapy for stage III nonsmall-cell lung cancer.

14/05/2021
/ Publications
/
Dosimetry
Toxicity

This study reported outcomes of 45 patients with stage III NSCLC treated with PBT of 74 GyE and concurrent chemotherapy. With a median follow-up time of 42.1...

Exposure of the heart in lung cancer radiation therapy: A systematic review of heart doses published during 2013 to 2020.

01/07/2022
/ Publications
/
Dosimetry
IMRT
Motion Management

Data of 140 dosimetry studies was analyzed. In the 105 non-SABR studies, the average MHD was similar between IMRT and 3DCRT (10.9 Gy versus 10.6 Gy) and lower...